(Q40396031)

English

In vitro evaluation of the astatinated chimeric monoclonal antibody U36, a potential candidate for treatment of head and neck squamous cell carcinoma

scientific article published on 19 July 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

In vitro evaluation of the astatinated chimeric monoclonal antibody U36, a potential candidate for treatment of head and neck squamous cell carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Vladimir Tolmachev

7

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

author name string

Nestor M

1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Persson M

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

van Dongen GA

3

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Jensen HJ

4

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Lundqvist H

5

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Anniko M

6

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

publication date

19 July 2005

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

European Journal of Nuclear Medicine and Molecular Imaging

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

1296-1304

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

The National Cancer Data Base report on cancer of the head and neck.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-005-1848-2

21 January 2018

Global cancer statistics in the year 2000.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-005-1848-2

21 January 2018

Estimating the world cancer burden: Globocan 2000.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-005-1848-2

21 January 2018

Cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1007%2FS00259-005-1848-2

21 January 2018

Development of distant metastasis after treatment of advanced-stage head and neck cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-005-1848-2

21 January 2018

Tumour therapy with radionuclides: assessment of progress and problems.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-005-1848-2

21 January 2018

CD44v6: a target for antibody-based cancer therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00259-005-1848-2

21 January 2018

A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells

1 reference

https://api.crossref.org/works/10.1007%2FS00259-005-1848-2

21 January 2018

Selection of monoclonal antibody E48 IgG or U36 IgG for adjuvant radioimmunotherapy in head and neck cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS00259-005-1848-2

21 January 2018

Clinical significance of micrometastatic cells detected by E48 (Ly-6D) reverse transcription-polymerase chain reaction in bone marrow of head and neck cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS00259-005-1848-2

21 January 2018

Astatine-211-labeled radiotherapeutics: an emerging approach to targeted alpha-particle radiotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00259-005-1848-2

21 January 2018

Selective targeting of tumour neovasculature by a radiohalogenated human antibody fragment specific for the ED-B domain of fibronectin

1 reference

https://api.crossref.org/works/10.1007%2FS00259-005-1848-2

21 January 2018

Comparison of the biologic effects of MA5 and B-B4 monoclonal antibody labeled with iodine-131 and bismuth-213 on multiple myeloma.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-005-1848-2

21 January 2018

Biodistribution of the chimeric monoclonal antibody U36 radioiodinated with a closo-dodecaborate-containing linker. Comparison with other radioiodination methods

1 reference

https://api.crossref.org/works/10.1007%2FS00259-005-1848-2

21 January 2018

In vitro effects of free 211At,211At-albumin and 211At-monoclonal antibody compared to external photon irradiation on two human cancer cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/16028065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MAb U36, a novel monoclonal antibody successful in immunotargeting of squamous cell carcinoma of the head and neck.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16028065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model

1 reference

https://pubmed.ncbi.nlm.nih.gov/16028065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I therapy study of 186Re-labeled chimeric monoclonal antibody U36 in patients with squamous cell carcinoma of the head and neck

1 reference

https://pubmed.ncbi.nlm.nih.gov/16028065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Construction and characterization of the chimeric monoclonal antibody E48 for therapy of head and neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16028065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Astatine-211 labeling of an antimelanoma antibody and its Fab fragment using N-succinimidyl p-astatobenzoate: comparisons in vivo with the p-[125I]iodobenzoyl conjugate

1 reference

https://pubmed.ncbi.nlm.nih.gov/16028065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of a high-affinity monoclonal antibody specific for CD44v6 as candidate for immunotherapy of squamous cell carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/16028065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reinfusion of unprocessed, granulocyte colony-stimulating factor-stimulated whole blood allows dose escalation of 186Relabeled chimeric monoclonal antibody U36 radioimmunotherapy in a phase I dose escalation study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16028065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High dose rhenium-186-labeling of monoclonal antibodies for clinical application: pitfalls and solutions.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16028065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of CD44 isoforms in renal cell tumors. Positive correlation to tumor differentiation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16028065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How far have we come with solid (nonhematologic) tumor radioimmunotherapy?

1 reference

https://pubmed.ncbi.nlm.nih.gov/16028065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Astatine-211-labeled antibodies for treatment of disseminated ovarian cancer: an overview of results in an ovarian tumor model

1 reference

https://pubmed.ncbi.nlm.nih.gov/16028065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiation Effects on Cultured Human Lymphoid Cells Analysis using the growth extrapolation method

1 reference

https://pubmed.ncbi.nlm.nih.gov/16028065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radioimmunoscintigraphy and biodistribution of technetium-99m-labeled monoclonal antibody U36 in patients with head and neck cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16028065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the therapeutic efficacy of 211At- and 131I-labelled monoclonal antibody MOv18 in nude mice with intraperitoneal growth of human ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16028065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00259-005-1848-2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40396031&oldid=2203657150"